Genetic Technologies Ltd logo

Genetic Technologies Ltd - SERIES B

NEW
ASX:GTG (Australia)   8 % Cum Pref Registered Shs Series -B
A$ 0.039 (0%) Jun 30
At Loss
Market Cap:
A$ 5.67M ($ 4.00M)
Enterprise V:
A$ 5.53M ($ 3.89M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Genetic Technologies Ltd logo
Genetic Technologies Ltd

ISIN : AU000000GTG7

Share Class Description:

ASX:GTG: 8 % Cum Pref Registered Shs Series -B
Description
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin %
-82.73
OCF Margin %
-82.48

GF Value Rank

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2026-08-18 Est.)

ASX:GTG's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Genetic Technologies Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 7.665
EPS (TTM) (A$) -
Beta -0.5229
3-Year Sharpe Ratio -1
3-Year Sortino Ratio -1.08
Volatility % -
14-Day RSI -
14-Day ATR (A$) -
20-Day SMA (A$) 0.039
12-1 Month Momentum % -
52-Week Range (A$) 0.039 - 0.039
Shares Outstanding (Mil) 145.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genetic Technologies Ltd Filings

Filing Date Document Date Form
No Filing Data

Genetic Technologies Ltd Stock Events

Financials Calendars
Event Date Price (A$)
Second quarter earnings conference call for 2026 2026-02-26 0.04 (+0.00%)
Second quarter earnings results for 2026 2026-02-26 0.04 (+0.00%)
First quarter earnings results for 2026 2025-11-14 0.04 (+0.00%)
First quarter earnings conference call for 2026 2025-11-14 0.04 (+0.00%)
General meeting for 2025 2025-10-31 0.04 (+0.00%)
Fourth quarter earnings results for 2025 2025-08-29 0.04 (+0.00%)
Third quarter earnings conference call for 2025 2025-08-18 0.04 (+0.00%)
Third quarter earnings results for 2025 2025-08-18 0.04 (+0.00%)
Annual report for 2024 2024-09-30 0.04 (+0.00%)
0.01:1 Stock Split 2023-12-14 0.20 (+0.00%)
Show
Entries

Genetic Technologies Ltd Frequently Asked Questions

What is Genetic Technologies Ltd(ASX:GTG)'s stock price today?
The current price of ASX:GTG is A$0.04. The 52 week high of ASX:GTG is A$0.04 and 52 week low is A$0.04.
When is next earnings date of Genetic Technologies Ltd(ASX:GTG)?
The next earnings date of Genetic Technologies Ltd(ASX:GTG) is 2026-08-18 Est..
Does Genetic Technologies Ltd(ASX:GTG) pay dividends? If so, how much?
Genetic Technologies Ltd(ASX:GTG) does not pay dividend.

Articles on Genetic Technologies Ltd

No articles.